Overview
- Shanghai Ladder Medical’s implantable wireless BCI has entered the NMPA/CMDE innovation special review, the first invasive BCI in China to reach the prioritized pathway.
- Entry into the green channel provides expedited technical review and guidance but does not constitute market approval.
- Company materials highlight a compact implant about coin-sized at 26 mm in diameter and under 6 mm thick, reported as roughly half the size of Neuralink’s device.
- Eastern Theater General Hospital in Nanjing opened Jiangsu’s first dedicated BCI ward and completed a semi-invasive clinical research surgery during its buildout.
- A three-month postoperative check noted improved right-hand function, and clinicians target high cervical spinal cord injury patients first with plans to extend to stroke hemiplegia and Parkinson’s, while emphasizing epidural placement as a safety advantage over intracortical approaches.